Patient #1 | Patient #2 | Patient #3 | Patient #4 | |
---|---|---|---|---|
Demographics | ||||
Age at baseline (years) | 35 | 69 | 43 | 67 |
Sex | Male | Female | Female | Female |
Baseline | ||||
Ferritin (15–247 μg/L) | 103 | 79 | 7 | 10 |
CRP (< 4.8 mg/L) | 0.4 | 2.4 | < 0.3 | 2.1 |
C4 (0.09–0.50 g/L) | 0.03 | 0.07 | 0.02 | 0.07 |
C1- INH function (0.70–1.30 U) | 0.16 | 0.25 | 0.12 | 0.30 |
Illness #1 | ||||
Ferritin (15–247 μg/L) | 121 | 93 | 9 | 49 ↑ |
CRP (< 4.8 mg/L) | 4.2 | 3.6 | 0.3 | 5.6 ↑ |
C4 (0.09–0.50 g/L) | 0.05 | 0.08 | 0.04 | 0.12 ↑ |
C1-INH function (0.70–1.30 U) | 0.22 | 0.28 | 0.14 | 0.37 |
Symptoms experienced | Fever, chills, sore throat | Sore throat, rhinorrhea, nasal congestion | Fever, muscle aches, congestion, fatigue | Cough, sore throat, rhinorrhea, congestion |
Duration of illness (days) | 2 | 2 | 7 | 18 |
Severity of illness (1–5) | 3 | 1 | 2 | 2 |
HAE attack within preceding 48 h (Y/N) | N | N | N | N |
Illness #2 | ||||
Ferritin (15–247 μg/L) | 123 | 40 ↑ | ||
CRP (< 4.8 mg/L) | 13.9 ↑ | 2.5 | ||
C4 (0.09–0.50 g/L) | 0.10 ↑ | 0.13 ↑ | ||
C1-INH function (0.70–1.30 U) | 0.24 | 0.34 | ||
Symptoms experienced | Cough, rhinorrhea | Cough, sore throat, rhinorrhea, congestion | ||
Duration of illness (days) | Not recorded | 16 | ||
Severity of illness (1–5) | 1 | 2 | ||
HAE attack within preceding 48 h (Y/N) | N | N |